VSee Health, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $14.6M | $10.4M | $5.8M |
| Cost of Revenue | $7.3M | $3.2M | $1.9M |
| Gross Profit | $7.4M | $7.2M | $3.8M |
| Gross Margin | 50.3% | 68.9% | 66.5% |
| Operating Expenses | |||
| Research & Development | — | — | — |
| SG&A Expense | $10.0M | $6.6M | $1.2M |
| Operating Income | $-9.6M | $-62.2M | $-1.9M |
| Operating Margin | -65.6% | -596.4% | -32.5% |
| Interest Expense | — | — | — |
| Pretax Income | $-14.6M | $-59.3M | $-1.9M |
| Income Tax Expense | $68.4K | $-1.6M | $1.8M |
| Net Income | $-14.7M | $-57.7M | $-3.8M |
| Net Margin | -100.6% | -553.7% | -65.3% |
| EPS (Basic) | $-0.73 | $-5.65 | $-0.38 |
| EPS (Diluted) | $-0.73 | $-5.65 | $-0.38 |
| Shares Outstanding (Basic) | 20.1M | 10.2M | 10.0M |
| Shares Outstanding (Diluted) | 20.1M | 10.2M | 10.0M |
| Dividends Per Share | — | — | — |